Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinations.
Decalf J, Toy E, He D, Kenkre R, Berkley AM, Wong D, Kwong M, Kee YS, Sun Y, Myneni S, Wang X, Ebtikar A, Ancheta A, Yang Y, Kim HS, Tang N, Banerji D, Mai E, Dogra P, McLerie M, Gutierrez AG, Strasser G, Rao GK, Betzenhauser M, Phung W, Day P, Sandoval W, Ovacik AM, Chan P, Sanjabi S, Comps-Agrar L, Cohen S, Ernst JA, Lazar GA, Kemball CC, Hosseini I, Liu Y, Schartner JM, Bainbridge TW, Moussion C.
Decalf J, et al.
EBioMedicine. 2025 Aug;118:105822. doi: 10.1016/j.ebiom.2025.105822. Epub 2025 Jul 5.
EBioMedicine. 2025.
PMID: 40618511
Free PMC article.